Open Beta
TREN
MetriLume
TREN

US marketsDARE

SEC-sourced researchBeta

DARE

Dare Bioscience, Inc.

Company comparison ↗

Data passport

CIK
0001401914
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 9,784.0000 USD; December 2025: 1,030,193.0000 USD1M USD0 USD0December 2024December 2025
DARE · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20249,784.0000Mar 26, 2026
December 20251,030,193.0000Mar 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,030,193.0000-13,399,274.0000-9,885,870.000032,474,563.000029,631,929.0000Mar 26, 2026
December 20249,784.0000-4,053,599.00005,473,555.000022,101,131.000028,113,220.0000Mar 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$1.03MDecember 2025Mar 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$9.78KDecember 2024Mar 26, 202610-K
Net incomeNetIncomeLoss-$13.4MDecember 2025Mar 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$9.89MDecember 2025Mar 26, 202610-K
Total assetsAssets$32.47MDecember 2025Mar 26, 202610-K
Total liabilitiesLiabilities$29.63MDecember 2025Mar 26, 202610-K

New filings

Explore methodology ↗